1. Home
  2. RDIB vs HRTX Comparison

RDIB vs HRTX Comparison

Compare RDIB & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDIB
  • HRTX
  • Stock Information
  • Founded
  • RDIB 1937
  • HRTX 1983
  • Country
  • RDIB United States
  • HRTX United States
  • Employees
  • RDIB N/A
  • HRTX N/A
  • Industry
  • RDIB Movies/Entertainment
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDIB Consumer Discretionary
  • HRTX Health Care
  • Exchange
  • RDIB Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • RDIB 259.2M
  • HRTX 242.0M
  • IPO Year
  • RDIB N/A
  • HRTX 1987
  • Fundamental
  • Price
  • RDIB $10.99
  • HRTX $1.32
  • Analyst Decision
  • RDIB
  • HRTX Strong Buy
  • Analyst Count
  • RDIB 0
  • HRTX 2
  • Target Price
  • RDIB N/A
  • HRTX $4.50
  • AVG Volume (30 Days)
  • RDIB 10.7K
  • HRTX 1.5M
  • Earning Date
  • RDIB 11-13-2025
  • HRTX 11-11-2025
  • Dividend Yield
  • RDIB N/A
  • HRTX N/A
  • EPS Growth
  • RDIB N/A
  • HRTX N/A
  • EPS
  • RDIB N/A
  • HRTX N/A
  • Revenue
  • RDIB $219,213,000.00
  • HRTX $149,694,000.00
  • Revenue This Year
  • RDIB $5.21
  • HRTX $10.62
  • Revenue Next Year
  • RDIB $11.45
  • HRTX $12.99
  • P/E Ratio
  • RDIB N/A
  • HRTX N/A
  • Revenue Growth
  • RDIB 7.59
  • HRTX 9.78
  • 52 Week Low
  • RDIB $5.78
  • HRTX $1.04
  • 52 Week High
  • RDIB $14.95
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • RDIB 45.53
  • HRTX 49.93
  • Support Level
  • RDIB $10.22
  • HRTX $1.28
  • Resistance Level
  • RDIB $11.55
  • HRTX $1.38
  • Average True Range (ATR)
  • RDIB 0.57
  • HRTX 0.06
  • MACD
  • RDIB -0.04
  • HRTX 0.01
  • Stochastic Oscillator
  • RDIB 37.38
  • HRTX 58.06

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: